Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06890988 · ClinicalTrials.gov registry record · NA
Ending the Epidemic Interventions in the Dental Setting - UH3
A NA study of HIV-1-infection, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 3
- Study locations
NCT06890988: Recruiting NA study of HIV-1-infection, sponsored by Columbia University.
NCT06890988 is a NA study of HIV-1-infection that is actively recruiting participants, run by Columbia University. The registered enrollment target is 128 participants, below the 350-participant average among 71 other HIV-1-infection trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06890988, a NA study of HIV-1-infection, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting.
Primary Outcome
Proportion of patients receiving clinical decision support (CDS) prompts for HIV testing that complete point of care HIV testing over the intervention period under the Enhanced versus Standard Dental Care Models.
Conditions Studied
Interventions
- OTHER Care Navigator
- OTHER Multicomponent HIV Service Package
Study Locations (3)
New York
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York
- Weill Cornell Medical Center / NewYork-Presbyterian Hospital - New York
- NYP-Queens - Queens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What NCT06890988 shows while recruiting
NCT06890988 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 350-participant average among 71 other HIV-1-infection trials with a reported enrollment target (63% lower).
The record links to 1 condition, with HIV-1-infection appearing as the primary indexed condition, and to 2 interventions - of which Care Navigator is the first listed.
NCT06890988 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06890988 about?
NCT06890988 is a clinical study titled "Ending the Epidemic Interventions in the Dental Setting - UH3". The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting.
What is the current status of trial NCT06890988?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-03-31. Estimated completion is 2027-09-01.
What conditions does trial NCT06890988 study?
This clinical trial studies the following conditions: HIV-1-infection.
What interventions are being tested in trial NCT06890988?
The interventions under investigation include: Care Navigator (OTHER), Multicomponent HIV Service Package (OTHER).
Who is sponsoring clinical trial NCT06890988?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06890988 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV-1-infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06890988's enrollment target sits among peer trials
128 26th of 71 higher than 46 of 71 other HIV-1-infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV-1-infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
RECRUITING · NA
-
Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV
ACTIVE NOT RECRUITING · NA
-
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
COMPLETED · NA
-
Acute Neural and Immune Effects of Alcohol in People Living With HIV Infection
COMPLETED · NA
-
A Mobile Intervention to Promote Cessation in HIV-infected Smokers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI